AQR Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.17M Buy
252,333
+160,286
+174% +$5.83M 0.01% 1000
2025
Q1
$3.31M Sell
92,047
-188,500
-67% -$6.77M ﹤0.01% 1333
2024
Q4
$11.8M Sell
280,547
-763,826
-73% -$32.1M 0.02% 784
2024
Q3
$57.8M Buy
1,044,373
+947,273
+976% +$52.4M 0.08% 330
2024
Q2
$3.99M Sell
97,100
-154,097
-61% -$6.33M 0.01% 1118
2024
Q1
$11.7M Buy
251,197
+80,508
+47% +$3.74M 0.02% 669
2023
Q4
$8.16M Buy
+170,689
New +$8.16M 0.02% 770
2023
Q2
Sell
-35,911
Closed -$1.41M 2262
2023
Q1
$1.41M Buy
35,911
+19,997
+126% +$782K ﹤0.01% 1404
2022
Q4
$729K Buy
15,914
+5,692
+56% +$261K ﹤0.01% 1673
2022
Q3
$423K Buy
+10,222
New +$423K ﹤0.01% 1848
2021
Q3
Sell
-9,500
Closed -$906K 2311
2021
Q2
$906K Sell
9,500
-19,284
-67% -$1.84M ﹤0.01% 1632
2021
Q1
$3.28M Sell
28,784
-9,234
-24% -$1.05M 0.01% 953
2020
Q4
$5.26M Buy
38,018
+8,959
+31% +$1.24M 0.01% 768
2020
Q3
$2.39M Buy
29,059
+1,576
+6% +$130K ﹤0.01% 1030
2020
Q2
$2.15M Buy
27,483
+3,836
+16% +$300K ﹤0.01% 1126
2020
Q1
$1.05M Buy
23,647
+18,220
+336% +$810K ﹤0.01% 1320
2019
Q4
$232K Buy
+5,427
New +$232K ﹤0.01% 1972
2019
Q3
Sell
-7,283
Closed -$462K 2148
2019
Q2
$462K Buy
+7,283
New +$462K ﹤0.01% 1753
2019
Q1
Sell
-7,858
Closed -$342K 2207
2018
Q4
$342K Buy
7,858
+976
+14% +$42.5K ﹤0.01% 1922
2018
Q3
$525K Buy
+6,882
New +$525K ﹤0.01% 1942
2016
Q3
Sell
-6,419
Closed -$314K 2284
2016
Q2
$314K Sell
6,419
-11,924
-65% -$583K ﹤0.01% 2002
2016
Q1
$1.16M Sell
18,343
-14,750
-45% -$934K ﹤0.01% 1516
2015
Q4
$3.71M Sell
33,093
-1,684
-5% -$189K 0.01% 1004
2015
Q3
$3.35M Buy
34,777
+12,185
+54% +$1.17M 0.01% 927
2015
Q2
$2.31M Buy
+22,592
New +$2.31M ﹤0.01% 1124